UnitedHealth Group Inc. (NYSE:UNH) is Most oversold S&P 500 shares so far in 2025. While the stock only fell slightly in 2024, the stock fell sharply in 2025, putting it among the top three stocks. The downturn mainly started with a revision of weaker quarterly results and guidance in April 2025 and further exacerbated guidance by the CEO's resignation and guidance in May.
With the company's earnings results, the company's revenue results, guidance and management's growth plans have been re-examined. On July 9, Barclays analyst Andrew Mok revised the company's price target, reducing it from $350 to $337 before the company's second-quarter earnings release on July 29. Despite adjustments, he maintained his buy rating for the stock.
Analysts target price targets but see long-term value of UnitedHealth (UNH)
An older Medicare-eligible consumer smiles happily while receiving medical services in the clinic.
The lower target reflects the decrease in MOK's EPS forecast for 2026. While he has not changed his positive view of the company's long-term potential, the revisions suggest that in the coming years, the stance on its earnings prospects will be more cautious.
Wolf research analyst Justin Lake has taken a similar move, reducing his stock's target price from $363 to $330, while reiterating his July 10 buy rating. Due to the headwinds of Medicaid and Health Insurance Exchanges, Lake now has pencils in lower EPS, and higher spending makes the company drive the company.
UnitedHealth Group Inc. (NYSE:UNH) is a healthcare company that provides health insurance and healthcare solutions in the United States and under UnitedHealthCare and Optum Brands.
Although we acknowledge UNH’s potential as an investment, we believe that certain AI stocks have greater upside potential and smaller downside risks. If you are looking for an undervalued AI stock that will also benefit greatly from the Trump era tariffs and open trends, see our related free reports Best Short-term AI Stocks.
Read the next article: Harvard University Stock Portfolio: Top 10 Stock Draft Picks And 20 takeoff momentum stocks are undervalued.
Disclosure: None. This article was originally published in Internal monkey.